Published in Circulation on September 11, 2007
Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell (2013) 1.86
Endothelial differentiation of amniotic fluid-derived stem cells: synergism of biochemical and shear force stimuli. Stem Cells Dev (2009) 1.20
The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells. Biomaterials (2009) 1.19
Programming and reprogramming a human heart cell. EMBO J (2015) 0.92
EMT-inducing biomaterials for heart valve engineering: taking cues from developmental biology. J Cardiovasc Transl Res (2011) 0.91
Tissue engineering on matrix: future of autologous tissue replacement. Semin Immunopathol (2011) 0.90
CD117(+) amniotic fluid stem cells: state of the art and future perspectives. Organogenesis (2012) 0.89
New technologies for surgery of the congenital cardiac defect. Rambam Maimonides Med J (2013) 0.83
Differentiation and Distribution of Marrow Stem Cells in Flex-Flow Environments Demonstrate Support of the Valvular Phenotype. PLoS One (2015) 0.81
Heart Valve Replacements with Regenerative Capacity. Transfus Med Hemother (2016) 0.80
Applications of amniotic membrane and fluid in stem cell biology and regenerative medicine. Stem Cells Int (2012) 0.80
A Mini Overview of Isolation, Characterization and Application of Amniotic Fluid Stem Cells. Int J Stem Cells (2015) 0.79
Congenital anomalies: treatment options based on amniotic fluid-derived stem cells. Organogenesis (2012) 0.78
Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs). Organogenesis (2013) 0.78
Amniotic fluid-derived stem cells for cardiovascular tissue engineering applications. Tissue Eng Part B Rev (2013) 0.78
Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions. Cell Cycle (2016) 0.77
How to make a heart valve: from embryonic development to bioengineering of living valve substitutes. Cold Spring Harb Perspect Med (2014) 0.77
Living-engineered valves for transcatheter venous valve repair. Tissue Eng Part C Methods (2014) 0.75
Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med (2005) 3.10
Aggravation of viral hepatitis by platelet-derived serotonin. Nat Med (2008) 3.10
Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood (2011) 2.92
Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. J Clin Invest (2006) 2.63
Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo. Nat Med (2003) 2.62
Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo. J Exp Med (2002) 2.47
Stroke volume and pulse pressure variation for prediction of fluid responsiveness in patients undergoing off-pump coronary artery bypass grafting. Chest (2005) 2.37
Novadaq SPY: intraoperative quality assessment in off-pump coronary artery bypass grafting. Chest (2004) 2.30
Accuracy of dual-source CT coronary angiography: First experience in a high pre-test probability population without heart rate control. Eur Radiol (2006) 2.17
Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res (2009) 2.16
Polyclonal and specific antibodies mediate protective immunity against enteric helminth infection. Cell Host Microbe (2008) 2.15
TCR affinity and negative regulation limit autoimmunity. Nat Med (2004) 1.94
Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses. Proc Natl Acad Sci U S A (2006) 1.92
Dual-source computed tomography coronary angiography: influence of obesity, calcium load, and heart rate on diagnostic accuracy. Eur Heart J (2008) 1.75
2-Methoxyestradiol, an estradiol metabolite, inhibits neointima formation and smooth muscle cell growth via double blockade of the cell cycle. Circ Res (2006) 1.70
Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells. Ann Thorac Surg (2002) 1.69
Dual-source CT in step-and-shoot mode: noninvasive coronary angiography with low radiation dose. Radiology (2008) 1.67
Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis. Hypertension (2007) 1.64
Is off-pump superior to conventional coronary artery bypass grafting in diabetic patients with multivessel disease? Eur J Cardiothorac Surg (2010) 1.59
Coronary artery imaging with 64-slice computed tomography from cardiac surgical perspective. Eur J Cardiothorac Surg (2006) 1.57
Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics (2004) 1.56
New transverse plate fixation system for complicated sternal wound infection after median sternotomy. Ann Thorac Surg (2007) 1.53
Gene regulatory control of myocardial energy metabolism predicts postoperative cardiac function in patients undergoing off-pump coronary artery bypass graft surgery: inhalational versus intravenous anesthetics. Anesthesiology (2007) 1.51
Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance. J Exp Med (2002) 1.48
Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell-dependent B cell responses. Nat Immunol (2003) 1.45
Despite modern off-pump coronary artery bypass grafting women fare worse than men. Interact Cardiovasc Thorac Surg (2010) 1.42
Natural IgE production in the absence of MHC Class II cognate help. Immunity (2006) 1.40
Accuracy of dual-source computed tomography coronary angiography: evaluation with a standardised protocol for cardiac surgeons. Eur J Cardiothorac Surg (2009) 1.38
ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-alpha/IL-6 in mice. Gastroenterology (2003) 1.37
Innate immune-induced depletion of bone marrow neutrophils aggravates systemic bacterial infections. Proc Natl Acad Sci U S A (2009) 1.35
Cooperative phagocytes: resident microglia and bone marrow immigrants remove dead photoreceptors in retinal lesions. Am J Pathol (2009) 1.33
Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells. Proc Natl Acad Sci U S A (2002) 1.33
Elimination of chronic viral infection by blocking CD27 signaling. J Exp Med (2006) 1.32
Mechanisms of neonatal mucosal antibody protection. J Immunol (2006) 1.32
Tissue engineering of human heart valve leaflets: a novel bioreactor for a strain-based conditioning approach. Ann Biomed Eng (2005) 1.32
Impaired antibody response causes persistence of prototypic T cell-contained virus. PLoS Biol (2009) 1.31
Design of custom-shaped vascularized tissues using microtissue spheroids as minimal building units. Tissue Eng (2006) 1.29
Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation (2002) 1.28
Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of beta1 and beta2 integrins. J Leukoc Biol (2006) 1.26
How good patient blood management leads to excellent outcomes in Jehovah's witness patients undergoing cardiac surgery. Interact Cardiovasc Thorac Surg (2010) 1.26
Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry. J Clin Oncol (2006) 1.25
Image quality and reconstruction intervals of dual-source CT coronary angiography: recommendations for ECG-pulsing windowing. Invest Radiol (2007) 1.25
Pre- and postoperative evaluation of congenital heart disease in children and adults with 64-section CT. Radiographics (2007) 1.24
Antiviral immune responses in the absence of organized lymphoid T cell zones in plt/plt mice. J Immunol (2002) 1.24
A novel concept for scaffold-free vessel tissue engineering: self-assembly of microtissue building blocks. J Biotechnol (2010) 1.22
Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells. J Am Coll Cardiol (2010) 1.19
Radiation dose of cardiac dual-source CT: the effect of tailoring the protocol to patient-specific parameters. Eur J Radiol (2008) 1.19
Marginal zone macrophages and immune responses against viruses. J Immunol (2002) 1.18
Extralymphatic virus sanctuaries as a consequence of potent T-cell activation. Nat Med (2007) 1.17
Fibrin as a cell carrier in cardiovascular tissue engineering applications. Biomaterials (2005) 1.16
PKCtheta signals activation versus tolerance in vivo. J Exp Med (2004) 1.15
Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling. J Heart Valve Dis (2002) 1.13
Rapid response of marginal zone B cells to viral particles. J Immunol (2004) 1.13
The role of collagen cross-links in biomechanical behavior of human aortic heart valve leaflets--relevance for tissue engineering. Tissue Eng (2007) 1.12
Myocardial bridging: depiction rate and morphology at CT coronary angiography--comparison with conventional coronary angiography. Radiology (2008) 1.10
Decellularized homologous tissue-engineered heart valves as off-the-shelf alternatives to xeno- and homografts. Biomaterials (2012) 1.08
Rapid functional exhaustion and deletion of CTL following immunization with recombinant adenovirus. J Immunol (2005) 1.08
Functional growth in tissue-engineered living, vascular grafts: follow-up at 100 weeks in a large animal model. Circulation (2006) 1.08
The inducible costimulator plays the major costimulatory role in humoral immune responses in the absence of CD28. J Immunol (2004) 1.08
Fucosyltransferase VII-deficient mice with defective E-, P-, and L-selectin ligands show impaired CD4+ and CD8+ T cell migration into the skin, but normal extravasation into visceral organs. J Immunol (2002) 1.07
Left atrial appendage clip occlusion: early clinical results. J Thorac Cardiovasc Surg (2009) 1.07
PARP1 is required for adhesion molecule expression in atherogenesis. Cardiovasc Res (2007) 1.06
Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodies. Proc Natl Acad Sci U S A (2003) 1.06
Influence of inflow cannula length in axial-flow pumps on neurologic adverse event rate: results from a multi-center analysis. J Heart Lung Transplant (2008) 1.06
Aortic valve replacement through a minimally invasive approach: preoperative planning, surgical technique, and outcome. Ann Thorac Surg (2009) 1.05
Off-the-shelf human decellularized tissue-engineered heart valves in a non-human primate model. Biomaterials (2013) 1.05
Flt3 ligand-treated neonatal mice have increased innate immunity against intracellular pathogens and efficiently control virus infections. J Exp Med (2003) 1.05
Engineering of biologically active living heart valve leaflets using human umbilical cord-derived progenitor cells. Tissue Eng (2006) 1.04
Accuracy of 64-slice computed tomography for the preoperative detection of coronary artery disease in patients with chronic aortic regurgitation. Am J Cardiol (2007) 1.02
Living autologous heart valves engineered from human prenatally harvested progenitors. Circulation (2006) 1.02
Tissue-engineering bioreactors: a new combined cell-seeding and perfusion system for vascular tissue engineering. Tissue Eng (2002) 1.01
Right-sided univentricular cardiac assistance in a failing Fontan circulation. Ann Thorac Surg (2008) 1.01
Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy. Eur Heart J (2010) 1.01
Autologous human tissue-engineered heart valves: prospects for systemic application. Circulation (2006) 1.00
Tailoring fiber diameter in electrospun poly(epsilon-caprolactone) scaffolds for optimal cellular infiltration in cardiovascular tissue engineering. Tissue Eng Part A (2009) 1.00
Gold-coated pacemaker implantation after allergic reactions to pacemaker compounds. Europace (2009) 1.00
VEGF profiling and angiogenesis in human microtissues. J Biotechnol (2005) 1.00
Endovascular repair of extracranial carotid artery dissection: current status and level of evidence. J Vasc Interv Radiol (2008) 0.99
Efficient T cell repertoire selection in tetraparental chimeric mice independent of thymic epithelial MHC. Proc Natl Acad Sci U S A (2003) 0.99
On-pump versus off-pump coronary artery bypass surgery in high-risk patients: operative results of a prospective randomized trial (on-off study). J Thorac Cardiovasc Surg (2011) 0.99
Safe, effective and durable epicardial left atrial appendage clip occlusion in patients with atrial fibrillation undergoing cardiac surgery: first long-term results from a prospective device trial. Eur J Cardiothorac Surg (2013) 0.98